Mandatory labelling of drugs will not lead to growth of their cost, or deficit, said in an interview with TASS, the Minister of industry and trade of Russia Denis Manturov.
“The shortage of, and price increases, labelling, by definition, can not cause” – said the Minister.
Manturov said that the Ministry is already seeing results from marking. In particular, it allows to identify the pharmacies medicines for delivery to patients in hospitals. “Hospital drugs simply resold by unscrupulous employees of medical institutions. Labeling identifies such schemes, making the drug market transparent and, therefore, everything falls into place”, – said Manturov.
To prevent a shortage provides a number of mechanisms – they also should help companies, which for objective reasons are unable to mark a separate series of drugs after July 1, said the head of Department.
As for the cost of marking, according to Manturov, the operator marking – Centre for development of advanced technologies (CRPT) – bound free, that is, at their own expense to provide the codes for labeling medications not more than 20 rubles. “But in the expensive segment of drugs the cost of marking 50 cents for the code just doesn’t matter”, he said.